Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717249 · ClinicalTrials.gov registry record · NA
Vistakon Investigational Contact Lenses Worn for Daily Wear
A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 529
- Enrollment target
- 20
- Study locations
NCT00717249: Completed NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
NCT00717249 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 529 participants, above the 262-participant average among 90 other Myopia trials with a reported enrollment target (102% higher). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00717249, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 529 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study compares the performance of an investigational contact lens to a currently marketed lens.
Primary Outcome
Each subjects' eye was examined using a bio-microscope. Slit lamp findings were graded using a 5- point scale. (Grade 0, 1, 2, 3 and 4). The data was dichotomized by creating 2 groups. Eyes with Grade 3 or Grade 4; eyes with Grade 2 or lower. The number of eyes with Grade 3 or Grade 4 was reported.
Conditions Studied
Interventions
- DEVICE galyifilcon A control lens
- DEVICE galyfilcon A with a silver additive
Study Locations (20)
Ohio
- Drs. Quinn, Quinn and Associates - Athens
- Dr. Michael H. Greenburg, Inc. - Chagrin Falls
- Central Ohio Eyecare - Columbus
- James W. Kershaw OD, Inc. - North Olmsted
Pennsylvania
- West Hills Vision Center - Moon Township
- Nittany Eye Associates - State College
- Research Across America - Wyomissing
California
- Cole, Cole, and Krohn - Fresno
- Dr. James R. Dugue Family Optometrist - Mission Viejo
Colorado
- Fukai and Associates - Louisville
Florida
- Baymeadows Vision Center - Jacksonville
Illinois
- Eyecare Associates - Bloomington
Kansas
- Advantage Eyecare Associates, LLC - Neodesha
Missouri
- InSight Eyecare - Warrensburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 529 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-04 |
| Phase | NA |
What the finished NCT00717249 record still lists
NCT00717249 is an interventional study that assigns participants to a tested intervention. The registered 529 participants enrollment target is mid-sized for trials with a published cap, above the 262-participant average among 90 other Myopia trials with a reported enrollment target (102% higher).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which galyifilcon A control lens is the first listed.
NCT00717249 names 20 study sites across 14 states, led by Ohio, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT00717249 about?
NCT00717249 is a clinical study titled "Vistakon Investigational Contact Lenses Worn for Daily Wear". This study compares the performance of an investigational contact lens to a currently marketed lens.
What is the current status of trial NCT00717249?
This trial is currently completed. It is a NA study. The enrollment target is 529 participants. The study started on 2007-08. Estimated completion is 2008-04.
What conditions does trial NCT00717249 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT00717249?
The interventions under investigation include: galyifilcon A control lens (DEVICE), galyfilcon A with a silver additive (DEVICE).
Who is sponsoring clinical trial NCT00717249?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00717249 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00717249's enrollment target sits among peer trials
529 8th of 90 higher than 83 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06646276 · 530 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- NCT06703476 · 530 participants · Phase 3
A Study of Surgical Techniques During Cystectomy
- NCT06880744 · 530 participants · Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
- NCT07138040 · 530 participants · NA
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia